Cue Biopharma's IPO

Cue Biopharma raised a round of funding on January 02, 2018. Investors include Public.

Cue Biopharma (Cue), formerly Imagen Biopharma, is an immunotherapy company developing biologics engineered to selectively communicate with disease-relevant T cells for the treatment of cancer and aut…

Articles about Cue Biopharma's IPO: